150 results on '"Baral, Ranju"'
Search Results
2. Cost of illness due to respiratory syncytial virus acute lower respiratory tract infection among infants hospitalized in Argentina
3. Association between achieving adequate antenatal care and health-seeking behaviors: A study of Demographic and Health Surveys in 47 low- and middle-income countries
4. Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina
5. Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries
6. Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective
7. Value profile for respiratory syncytial virus vaccines and monoclonal antibodies
8. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
9. Assessing the Long-Term Economic Impact of Wheezing Episodes After Severe RSV Disease in Children from Argentina: A Cost of Illness Analysis
10. Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
11. The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature.
12. Cost of illness due to Respiratory Syncytial Virus Acute Lower Respiratory Tract Infection Among Infants Hospitalized in Argentina
13. Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study
14. Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries
15. Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016
16. Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022
17. Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis
18. Cost of introducing and delivering malaria vaccine (RTS,S/AS01E) in areas of seasonal malaria transmission, Mali and Burkina Faso
19. Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates
20. Adjusting health spending for the presence of comorbidities: an application to United States national inpatient data
21. Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program
22. Additional file 1 of Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries
23. Using National Data to Estimate Average Cost Effectiveness of EFNEP Outcomes by State/Territory
24. Respiratory Syncytial Virus (RSV) Disease and Prevention Products: Knowledge, Attitudes, and Preferences of Kenyan Healthcare Workers in Two Counties in 2021.
25. Costs and cost-effectiveness of malaria reactive case detection using loop-mediated isothermal amplification compared to microscopy in the low transmission setting of Aceh Province, Indonesia
26. Optimizing next-generation RSV prevention in Mali: a cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis
27. Using National Data to Estimate Average Cost Effectiveness of EFNEP Outcomes by State/Territory
28. Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions
29. Correction: Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries
30. Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model
31. Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries
32. Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in Malawi
33. Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage
34. Evaluation of the feasibility and effectiveness of a health facility-based combined with home-based early childhood development intervention in Siaya County, Kenya: a cluster-randomized control trial
35. The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models
36. Malaria elimination transmission and costing in the Asia-Pacific: Developing an investment case
37. Lessons learned from the Advancing Maternal Immunization collaboration: identifying evidence gaps for informed respiratory syncytial virus maternal immunization decision-making
38. Malaria elimination transmission and costing in the Asia-Pacific: Developing an investment case
39. Using pre- and post-survey instruments in interventions: determining the random response benchmark and its implications for measuring effectiveness
40. An Investment Case to Prevent the Reintroduction of Malaria in Sri Lanka
41. US Spending on Personal Health Care and Public Health, 1996-2013
42. Assessing the Complex and Evolving Relationship between Charges and Payments in US Hospitals: 1996 – 2012
43. Evaluating Cost Effectiveness of the USDA's Expanded Food and Nutrition Education Program
44. National, Regional, and State-Level Estimates of Returns to Scale in the Expanded Food and Nutrition Education Program
45. The Cost Effectiveness of Educating Limited Resource Youths on Food and Nutrition
46. What Have We Learned about the Cost and Effectiveness of the Expanded Food and Nutrition Education Program?
47. Using pre- and post-survey instruments in interventions: determining the random response benchmark and its implications for measuring effectiveness.
48. Evaluation of the Youth Expanded Food and Nutrition Education Program: What Contributes to its Effectiveness?
49. Returns to Scale and the Effectiveness of Money Spent on the Expanded Food and Nutrition Education Program
50. Consumption Time in Household Production: Implications for the Goods-Time Elasticity of Substitution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.